P

Inventor

DU XINYAO

CA30 patents
⚠️ This page may combine multiple inventors who share the name “DU XINYAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACUITAS THERAPEUTICS INC

23 patents
US10221127B2Mar 5, 2019

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC136 citations99
US10166298B2Jan 1, 2019

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC125 citations99
US10723692B2Jul 28, 2020

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC59 citations98
US10106490B2Oct 23, 2018

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC71 citations98
US9738593B2Aug 22, 2017

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC87 citations98
US9737619B2Aug 22, 2017

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC78 citations98
US11453639B2Sep 27, 2022

Lipids for lipid nanoparticle delivery of active agents

ACUITAS THERAPEUTICS INC16 citations94
US11357856B2Jun 14, 2022

Lipids for delivery of active agents

ACUITAS THERAPEUTICS INC20 citations94
US11168051B2Nov 9, 2021

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC20 citations94
US11040112B2Jun 22, 2021

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC26 citations94
US11648324B2May 16, 2023

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC5 citations86
US11634379B2Apr 25, 2023

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC7 citations86
US11542225B2Jan 3, 2023

Lipids for use in lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC8 citations86
US11524932B2Dec 13, 2022

Lipids for use in lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC8 citations86
US11712481B2Aug 1, 2023

Lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC11 citations82
US12065396B2Aug 20, 2024

Lipids for use in lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC5 citations75
US11820728B2Nov 21, 2023

Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids

ACUITAS THERAPEUTICS INC4 citations75
US11639329B2May 2, 2023

Lipids for use in lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC6 citations75
US11976019B2May 7, 2024

Cationic lipids for use in lipid nanoparticles

ACUITAS THERAPEUTICS INC4 citations70
US12129223B2Oct 29, 2024

Lipids for use in lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC4 citations66
US12151996B2Nov 26, 2024

Lipids for lipid nanoparticle delivery of active agents

ACUITAS THERAPEUTICS INC0 citations62
US12410121B2Sep 9, 2025

Cationic lipids for use in lipid nanoparticles

ACUITAS THERAPEUTICS INC0 citations58
US12491261B2Dec 9, 2025

Lipid nanoparticle formulations

ACUITAS THERAPEUTICS INC0 citations49

ALNYLAM PHARMACEUTICALS INC

1 patent

KINETEK PHARMACEUTICALS INC

1 patent

VALOCOR THERAPEUTICS INC

1 patent

OLT INC

1 patent

DERMIRA CANADA INC

1 patent

DERMIRA (CANADA) INC

1 patent

ZHANG ZAIHUI

1 patent